Global AI Biomedicine Service Supply, Demand and Key Producers, 2026-2032
The global AI Biomedicine Service market size is expected to reach $ 7704 million by 2032, rising at a market growth of 8.8% CAGR during the forecast period (2026-2032).
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
From a multi-dimensional classification and parameterization perspective, the market can be segmented by service focus (AI drug discovery, AI antibody/biologic discovery, AI pathology and biomarker services, AI omics analytics), by delivery model (platform-as-a-service, fee-for-service, co-development partnerships, or risk-sharing milestone models), and by data modality (chemical structures, protein structures, imaging pathology data, genomics, transcriptomics, and multi-omics). Key performance parameters used by customers include hit identification success rates, lead optimization cycles, reduction in wet-lab iterations, model generalizability across targets, and the ability to integrate proprietary datasets securely.
The industry value chain begins upstream with data generation sources such as high-throughput screening labs, biobanks, sequencing providers, and pathology laboratories, alongside cloud and computing infrastructure suppliers. Midstream players are AI Biomedicine Service providers that combine proprietary algorithms, curated datasets, and domain expertise to deliver discovery or analysis services. Downstream customers include pharmaceutical companies, biotech startups, and, increasingly, CROs and CDMOs integrating AI into their service portfolios. Strategic partnerships and long-term collaborations are common, often embedding AI services deeply into clients? R&D workflows.
From a profitability perspective, AI Biomedicine Services generally exhibit attractive gross margins, typically in the 60?80% range, reflecting their software- and data-driven nature. Margins vary by model: platform subscriptions and recurring service contracts achieve higher margins, while project-based discovery services see lower margins due to scientific labor and validation costs. Market momentum is driven by rising R&D costs, pressure to improve pipeline productivity, and growing acceptance of AI-derived insights by regulators and pharma partners. Key trends include consolidation between AI platforms and CROs, expansion from discovery into preclinical and translational stages, and increasing use of outcome-linked and co-development revenue models.
This report studies the global AI Biomedicine Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Biomedicine Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Biomedicine Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Biomedicine Service total market, 2021-2032, (USD Million)
Global AI Biomedicine Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Biomedicine Service total market, key domestic companies, and share, (USD Million)
Global AI Biomedicine Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Biomedicine Service total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Biomedicine Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Biomedicine Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcellera Biologics, Evotec, Atomwise, XtalPi, PathAI, Paige AI, HotSpot Therapeutics, Scorpion Therapeutics, Charm Therapeutics, LifeMine Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Biomedicine Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Biomedicine Service Market, By Region:
1. How big is the global AI Biomedicine Service market?
2. What is the demand of the global AI Biomedicine Service market?
3. What is the year over year growth of the global AI Biomedicine Service market?
4. What is the total value of the global AI Biomedicine Service market?
5. Who are the Major Players in the global AI Biomedicine Service market?
6. What are the growth factors driving the market demand?
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
From a multi-dimensional classification and parameterization perspective, the market can be segmented by service focus (AI drug discovery, AI antibody/biologic discovery, AI pathology and biomarker services, AI omics analytics), by delivery model (platform-as-a-service, fee-for-service, co-development partnerships, or risk-sharing milestone models), and by data modality (chemical structures, protein structures, imaging pathology data, genomics, transcriptomics, and multi-omics). Key performance parameters used by customers include hit identification success rates, lead optimization cycles, reduction in wet-lab iterations, model generalizability across targets, and the ability to integrate proprietary datasets securely.
The industry value chain begins upstream with data generation sources such as high-throughput screening labs, biobanks, sequencing providers, and pathology laboratories, alongside cloud and computing infrastructure suppliers. Midstream players are AI Biomedicine Service providers that combine proprietary algorithms, curated datasets, and domain expertise to deliver discovery or analysis services. Downstream customers include pharmaceutical companies, biotech startups, and, increasingly, CROs and CDMOs integrating AI into their service portfolios. Strategic partnerships and long-term collaborations are common, often embedding AI services deeply into clients? R&D workflows.
From a profitability perspective, AI Biomedicine Services generally exhibit attractive gross margins, typically in the 60?80% range, reflecting their software- and data-driven nature. Margins vary by model: platform subscriptions and recurring service contracts achieve higher margins, while project-based discovery services see lower margins due to scientific labor and validation costs. Market momentum is driven by rising R&D costs, pressure to improve pipeline productivity, and growing acceptance of AI-derived insights by regulators and pharma partners. Key trends include consolidation between AI platforms and CROs, expansion from discovery into preclinical and translational stages, and increasing use of outcome-linked and co-development revenue models.
This report studies the global AI Biomedicine Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Biomedicine Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Biomedicine Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Biomedicine Service total market, 2021-2032, (USD Million)
Global AI Biomedicine Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Biomedicine Service total market, key domestic companies, and share, (USD Million)
Global AI Biomedicine Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Biomedicine Service total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Biomedicine Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Biomedicine Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcellera Biologics, Evotec, Atomwise, XtalPi, PathAI, Paige AI, HotSpot Therapeutics, Scorpion Therapeutics, Charm Therapeutics, LifeMine Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Biomedicine Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Biomedicine Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- AI-driven Drug Discovery Services
- AI-based Preclinical Research Services
- AI-enabled Clinical Trial Services
- AI Biomarker & Companion Diagnostic Services
- Others
- Genomics & Multi-omics AI Services
- Medical Imaging & Digital Pathology AI Services
- Chemical & Molecular Structure AI Services
- Clinical & EHR Data AI Services
- Others
- Project-based AI Research Services
- Subscription-based AI Platforms (Service Mode)
- AI-as-a-Service (API / Cloud-based)
- Others
- Pharmaceutical & Biotech Companies
- CRO / CDMO-oriented Companies
- Academic & Research Institutes
- Others
- Abcellera Biologics
- Evotec
- Atomwise
- XtalPi
- PathAI
- Paige AI
- HotSpot Therapeutics
- Scorpion Therapeutics
- Charm Therapeutics
- LifeMine Therapeutics
- C4XD Discovery
- Wave Life Sciences
- Westlake Omics
- IIpharma
1. How big is the global AI Biomedicine Service market?
2. What is the demand of the global AI Biomedicine Service market?
3. What is the year over year growth of the global AI Biomedicine Service market?
4. What is the total value of the global AI Biomedicine Service market?
5. Who are the Major Players in the global AI Biomedicine Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Biomedicine Service Introduction
1.2 World AI Biomedicine Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Biomedicine Service Total Market by Region (by Headquarter Location)
1.3.1 World AI Biomedicine Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.3 China Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.4 Europe Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.5 Japan Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.6 South Korea Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.8 India Based Company AI Biomedicine Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Biomedicine Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Biomedicine Service Consumption Value (2021-2032)
2.2 World AI Biomedicine Service Consumption Value by Region
2.2.1 World AI Biomedicine Service Consumption Value by Region (2021-2026)
2.2.2 World AI Biomedicine Service Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Biomedicine Service Consumption Value (2021-2032)
2.4 China AI Biomedicine Service Consumption Value (2021-2032)
2.5 Europe AI Biomedicine Service Consumption Value (2021-2032)
2.6 Japan AI Biomedicine Service Consumption Value (2021-2032)
2.7 South Korea AI Biomedicine Service Consumption Value (2021-2032)
2.8 ASEAN AI Biomedicine Service Consumption Value (2021-2032)
2.9 India AI Biomedicine Service Consumption Value (2021-2032)
3 WORLD AI BIOMEDICINE SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Biomedicine Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Biomedicine Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Biomedicine Service in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Biomedicine Service in 2025
3.3 AI Biomedicine Service Company Evaluation Quadrant
3.4 AI Biomedicine Service Market: Overall Company Footprint Analysis
3.4.1 AI Biomedicine Service Market: Region Footprint
3.4.2 AI Biomedicine Service Market: Company Product Type Footprint
3.4.3 AI Biomedicine Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Biomedicine Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Biomedicine Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Biomedicine Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Biomedicine Service Consumption Value Comparison
4.2.1 United States VS China: AI Biomedicine Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Biomedicine Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Biomedicine Service Companies and Market Share, 2021-2026
4.3.1 United States Based AI Biomedicine Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Biomedicine Service Revenue, (2021-2026)
4.4 China Based Companies AI Biomedicine Service Revenue and Market Share, 2021-2026
4.4.1 China Based AI Biomedicine Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Biomedicine Service Revenue, (2021-2026)
4.5 Rest of World Based AI Biomedicine Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Biomedicine Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Biomedicine Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Biomedicine Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 AI-driven Drug Discovery Services
5.2.2 AI-based Preclinical Research Services
5.2.3 AI-enabled Clinical Trial Services
5.2.4 AI Biomarker & Companion Diagnostic Services
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World AI Biomedicine Service Market Size by Type (2021-2026)
5.3.2 World AI Biomedicine Service Market Size by Type (2027-2032)
5.3.3 World AI Biomedicine Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA TYPE & MODALITY
6.1 World AI Biomedicine Service Market Size Overview by Data Type & Modality: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Type & Modality
6.2.1 Genomics & Multi-omics AI Services
6.2.2 Medical Imaging & Digital Pathology AI Services
6.2.3 Chemical & Molecular Structure AI Services
6.2.4 Clinical & EHR Data AI Services
6.2.5 Others
6.3 Market Segment by Data Type & Modality
6.3.1 World AI Biomedicine Service Market Size by Data Type & Modality (2021-2026)
6.3.2 World AI Biomedicine Service Market Size by Data Type & Modality (2027-2032)
6.3.3 World AI Biomedicine Service Market Size Market Share by Data Type & Modality (2027-2032)
7 MARKET ANALYSIS BY SERVICE DELIVERY MODEL
7.1 World AI Biomedicine Service Market Size Overview by Service Delivery Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Delivery Model
7.2.1 Project-based AI Research Services
7.2.2 Subscription-based AI Platforms (Service Mode)
7.2.3 AI-as-a-Service (API / Cloud-based)
7.2.4 Others
7.3 Market Segment by Service Delivery Model
7.3.1 World AI Biomedicine Service Market Size by Service Delivery Model (2021-2026)
7.3.2 World AI Biomedicine Service Market Size by Service Delivery Model (2027-2032)
7.3.3 World AI Biomedicine Service Market Size Market Share by Service Delivery Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Biomedicine Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical & Biotech Companies
8.2.2 CRO / CDMO-oriented Companies
8.2.3 Academic & Research Institutes
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World AI Biomedicine Service Market Size by Application (2021-2026)
8.3.2 World AI Biomedicine Service Market Size by Application (2027-2032)
8.3.3 World AI Biomedicine Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Abcellera Biologics
9.1.1 Abcellera Biologics Details
9.1.2 Abcellera Biologics Major Business
9.1.3 Abcellera Biologics AI Biomedicine Service Product and Services
9.1.4 Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Abcellera Biologics Recent Developments/Updates
9.1.6 Abcellera Biologics Competitive Strengths & Weaknesses
9.2 Evotec
9.2.1 Evotec Details
9.2.2 Evotec Major Business
9.2.3 Evotec AI Biomedicine Service Product and Services
9.2.4 Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Evotec Recent Developments/Updates
9.2.6 Evotec Competitive Strengths & Weaknesses
9.3 Atomwise
9.3.1 Atomwise Details
9.3.2 Atomwise Major Business
9.3.3 Atomwise AI Biomedicine Service Product and Services
9.3.4 Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Atomwise Recent Developments/Updates
9.3.6 Atomwise Competitive Strengths & Weaknesses
9.4 XtalPi
9.4.1 XtalPi Details
9.4.2 XtalPi Major Business
9.4.3 XtalPi AI Biomedicine Service Product and Services
9.4.4 XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 XtalPi Recent Developments/Updates
9.4.6 XtalPi Competitive Strengths & Weaknesses
9.5 PathAI
9.5.1 PathAI Details
9.5.2 PathAI Major Business
9.5.3 PathAI AI Biomedicine Service Product and Services
9.5.4 PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 PathAI Recent Developments/Updates
9.5.6 PathAI Competitive Strengths & Weaknesses
9.6 Paige AI
9.6.1 Paige AI Details
9.6.2 Paige AI Major Business
9.6.3 Paige AI AI Biomedicine Service Product and Services
9.6.4 Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Paige AI Recent Developments/Updates
9.6.6 Paige AI Competitive Strengths & Weaknesses
9.7 HotSpot Therapeutics
9.7.1 HotSpot Therapeutics Details
9.7.2 HotSpot Therapeutics Major Business
9.7.3 HotSpot Therapeutics AI Biomedicine Service Product and Services
9.7.4 HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 HotSpot Therapeutics Recent Developments/Updates
9.7.6 HotSpot Therapeutics Competitive Strengths & Weaknesses
9.8 Scorpion Therapeutics
9.8.1 Scorpion Therapeutics Details
9.8.2 Scorpion Therapeutics Major Business
9.8.3 Scorpion Therapeutics AI Biomedicine Service Product and Services
9.8.4 Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Scorpion Therapeutics Recent Developments/Updates
9.8.6 Scorpion Therapeutics Competitive Strengths & Weaknesses
9.9 Charm Therapeutics
9.9.1 Charm Therapeutics Details
9.9.2 Charm Therapeutics Major Business
9.9.3 Charm Therapeutics AI Biomedicine Service Product and Services
9.9.4 Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Charm Therapeutics Recent Developments/Updates
9.9.6 Charm Therapeutics Competitive Strengths & Weaknesses
9.10 LifeMine Therapeutics
9.10.1 LifeMine Therapeutics Details
9.10.2 LifeMine Therapeutics Major Business
9.10.3 LifeMine Therapeutics AI Biomedicine Service Product and Services
9.10.4 LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 LifeMine Therapeutics Recent Developments/Updates
9.10.6 LifeMine Therapeutics Competitive Strengths & Weaknesses
9.11 C4XD Discovery
9.11.1 C4XD Discovery Details
9.11.2 C4XD Discovery Major Business
9.11.3 C4XD Discovery AI Biomedicine Service Product and Services
9.11.4 C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 C4XD Discovery Recent Developments/Updates
9.11.6 C4XD Discovery Competitive Strengths & Weaknesses
9.12 Wave Life Sciences
9.12.1 Wave Life Sciences Details
9.12.2 Wave Life Sciences Major Business
9.12.3 Wave Life Sciences AI Biomedicine Service Product and Services
9.12.4 Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Wave Life Sciences Recent Developments/Updates
9.12.6 Wave Life Sciences Competitive Strengths & Weaknesses
9.13 Westlake Omics
9.13.1 Westlake Omics Details
9.13.2 Westlake Omics Major Business
9.13.3 Westlake Omics AI Biomedicine Service Product and Services
9.13.4 Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Westlake Omics Recent Developments/Updates
9.13.6 Westlake Omics Competitive Strengths & Weaknesses
9.14 IIpharma
9.14.1 IIpharma Details
9.14.2 IIpharma Major Business
9.14.3 IIpharma AI Biomedicine Service Product and Services
9.14.4 IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 IIpharma Recent Developments/Updates
9.14.6 IIpharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Biomedicine Service Industry Chain
10.2 AI Biomedicine Service Upstream Analysis
10.3 AI Biomedicine Service Midstream Analysis
10.4 AI Biomedicine Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 AI Biomedicine Service Introduction
1.2 World AI Biomedicine Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Biomedicine Service Total Market by Region (by Headquarter Location)
1.3.1 World AI Biomedicine Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.3 China Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.4 Europe Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.5 Japan Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.6 South Korea Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Biomedicine Service Revenue (2021-2032)
1.3.8 India Based Company AI Biomedicine Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Biomedicine Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Biomedicine Service Consumption Value (2021-2032)
2.2 World AI Biomedicine Service Consumption Value by Region
2.2.1 World AI Biomedicine Service Consumption Value by Region (2021-2026)
2.2.2 World AI Biomedicine Service Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Biomedicine Service Consumption Value (2021-2032)
2.4 China AI Biomedicine Service Consumption Value (2021-2032)
2.5 Europe AI Biomedicine Service Consumption Value (2021-2032)
2.6 Japan AI Biomedicine Service Consumption Value (2021-2032)
2.7 South Korea AI Biomedicine Service Consumption Value (2021-2032)
2.8 ASEAN AI Biomedicine Service Consumption Value (2021-2032)
2.9 India AI Biomedicine Service Consumption Value (2021-2032)
3 WORLD AI BIOMEDICINE SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Biomedicine Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Biomedicine Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Biomedicine Service in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Biomedicine Service in 2025
3.3 AI Biomedicine Service Company Evaluation Quadrant
3.4 AI Biomedicine Service Market: Overall Company Footprint Analysis
3.4.1 AI Biomedicine Service Market: Region Footprint
3.4.2 AI Biomedicine Service Market: Company Product Type Footprint
3.4.3 AI Biomedicine Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Biomedicine Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Biomedicine Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Biomedicine Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Biomedicine Service Consumption Value Comparison
4.2.1 United States VS China: AI Biomedicine Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Biomedicine Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Biomedicine Service Companies and Market Share, 2021-2026
4.3.1 United States Based AI Biomedicine Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Biomedicine Service Revenue, (2021-2026)
4.4 China Based Companies AI Biomedicine Service Revenue and Market Share, 2021-2026
4.4.1 China Based AI Biomedicine Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Biomedicine Service Revenue, (2021-2026)
4.5 Rest of World Based AI Biomedicine Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Biomedicine Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Biomedicine Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Biomedicine Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 AI-driven Drug Discovery Services
5.2.2 AI-based Preclinical Research Services
5.2.3 AI-enabled Clinical Trial Services
5.2.4 AI Biomarker & Companion Diagnostic Services
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World AI Biomedicine Service Market Size by Type (2021-2026)
5.3.2 World AI Biomedicine Service Market Size by Type (2027-2032)
5.3.3 World AI Biomedicine Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DATA TYPE & MODALITY
6.1 World AI Biomedicine Service Market Size Overview by Data Type & Modality: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Data Type & Modality
6.2.1 Genomics & Multi-omics AI Services
6.2.2 Medical Imaging & Digital Pathology AI Services
6.2.3 Chemical & Molecular Structure AI Services
6.2.4 Clinical & EHR Data AI Services
6.2.5 Others
6.3 Market Segment by Data Type & Modality
6.3.1 World AI Biomedicine Service Market Size by Data Type & Modality (2021-2026)
6.3.2 World AI Biomedicine Service Market Size by Data Type & Modality (2027-2032)
6.3.3 World AI Biomedicine Service Market Size Market Share by Data Type & Modality (2027-2032)
7 MARKET ANALYSIS BY SERVICE DELIVERY MODEL
7.1 World AI Biomedicine Service Market Size Overview by Service Delivery Model: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Service Delivery Model
7.2.1 Project-based AI Research Services
7.2.2 Subscription-based AI Platforms (Service Mode)
7.2.3 AI-as-a-Service (API / Cloud-based)
7.2.4 Others
7.3 Market Segment by Service Delivery Model
7.3.1 World AI Biomedicine Service Market Size by Service Delivery Model (2021-2026)
7.3.2 World AI Biomedicine Service Market Size by Service Delivery Model (2027-2032)
7.3.3 World AI Biomedicine Service Market Size Market Share by Service Delivery Model (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World AI Biomedicine Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical & Biotech Companies
8.2.2 CRO / CDMO-oriented Companies
8.2.3 Academic & Research Institutes
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World AI Biomedicine Service Market Size by Application (2021-2026)
8.3.2 World AI Biomedicine Service Market Size by Application (2027-2032)
8.3.3 World AI Biomedicine Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Abcellera Biologics
9.1.1 Abcellera Biologics Details
9.1.2 Abcellera Biologics Major Business
9.1.3 Abcellera Biologics AI Biomedicine Service Product and Services
9.1.4 Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Abcellera Biologics Recent Developments/Updates
9.1.6 Abcellera Biologics Competitive Strengths & Weaknesses
9.2 Evotec
9.2.1 Evotec Details
9.2.2 Evotec Major Business
9.2.3 Evotec AI Biomedicine Service Product and Services
9.2.4 Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Evotec Recent Developments/Updates
9.2.6 Evotec Competitive Strengths & Weaknesses
9.3 Atomwise
9.3.1 Atomwise Details
9.3.2 Atomwise Major Business
9.3.3 Atomwise AI Biomedicine Service Product and Services
9.3.4 Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Atomwise Recent Developments/Updates
9.3.6 Atomwise Competitive Strengths & Weaknesses
9.4 XtalPi
9.4.1 XtalPi Details
9.4.2 XtalPi Major Business
9.4.3 XtalPi AI Biomedicine Service Product and Services
9.4.4 XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 XtalPi Recent Developments/Updates
9.4.6 XtalPi Competitive Strengths & Weaknesses
9.5 PathAI
9.5.1 PathAI Details
9.5.2 PathAI Major Business
9.5.3 PathAI AI Biomedicine Service Product and Services
9.5.4 PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 PathAI Recent Developments/Updates
9.5.6 PathAI Competitive Strengths & Weaknesses
9.6 Paige AI
9.6.1 Paige AI Details
9.6.2 Paige AI Major Business
9.6.3 Paige AI AI Biomedicine Service Product and Services
9.6.4 Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Paige AI Recent Developments/Updates
9.6.6 Paige AI Competitive Strengths & Weaknesses
9.7 HotSpot Therapeutics
9.7.1 HotSpot Therapeutics Details
9.7.2 HotSpot Therapeutics Major Business
9.7.3 HotSpot Therapeutics AI Biomedicine Service Product and Services
9.7.4 HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 HotSpot Therapeutics Recent Developments/Updates
9.7.6 HotSpot Therapeutics Competitive Strengths & Weaknesses
9.8 Scorpion Therapeutics
9.8.1 Scorpion Therapeutics Details
9.8.2 Scorpion Therapeutics Major Business
9.8.3 Scorpion Therapeutics AI Biomedicine Service Product and Services
9.8.4 Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Scorpion Therapeutics Recent Developments/Updates
9.8.6 Scorpion Therapeutics Competitive Strengths & Weaknesses
9.9 Charm Therapeutics
9.9.1 Charm Therapeutics Details
9.9.2 Charm Therapeutics Major Business
9.9.3 Charm Therapeutics AI Biomedicine Service Product and Services
9.9.4 Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Charm Therapeutics Recent Developments/Updates
9.9.6 Charm Therapeutics Competitive Strengths & Weaknesses
9.10 LifeMine Therapeutics
9.10.1 LifeMine Therapeutics Details
9.10.2 LifeMine Therapeutics Major Business
9.10.3 LifeMine Therapeutics AI Biomedicine Service Product and Services
9.10.4 LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 LifeMine Therapeutics Recent Developments/Updates
9.10.6 LifeMine Therapeutics Competitive Strengths & Weaknesses
9.11 C4XD Discovery
9.11.1 C4XD Discovery Details
9.11.2 C4XD Discovery Major Business
9.11.3 C4XD Discovery AI Biomedicine Service Product and Services
9.11.4 C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 C4XD Discovery Recent Developments/Updates
9.11.6 C4XD Discovery Competitive Strengths & Weaknesses
9.12 Wave Life Sciences
9.12.1 Wave Life Sciences Details
9.12.2 Wave Life Sciences Major Business
9.12.3 Wave Life Sciences AI Biomedicine Service Product and Services
9.12.4 Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Wave Life Sciences Recent Developments/Updates
9.12.6 Wave Life Sciences Competitive Strengths & Weaknesses
9.13 Westlake Omics
9.13.1 Westlake Omics Details
9.13.2 Westlake Omics Major Business
9.13.3 Westlake Omics AI Biomedicine Service Product and Services
9.13.4 Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Westlake Omics Recent Developments/Updates
9.13.6 Westlake Omics Competitive Strengths & Weaknesses
9.14 IIpharma
9.14.1 IIpharma Details
9.14.2 IIpharma Major Business
9.14.3 IIpharma AI Biomedicine Service Product and Services
9.14.4 IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 IIpharma Recent Developments/Updates
9.14.6 IIpharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 AI Biomedicine Service Industry Chain
10.2 AI Biomedicine Service Upstream Analysis
10.3 AI Biomedicine Service Midstream Analysis
10.4 AI Biomedicine Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World AI Biomedicine Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Biomedicine Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Biomedicine Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Biomedicine Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Biomedicine Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Biomedicine Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Biomedicine Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Biomedicine Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Biomedicine Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Biomedicine Service Players in 2025
Table 12. World AI Biomedicine Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Biomedicine Service Company Evaluation Quadrant
Table 14. Head Office of Key AI Biomedicine Service Players
Table 15. AI Biomedicine Service Market: Company Product Type Footprint
Table 16. AI Biomedicine Service Market: Company Product Application Footprint
Table 17. AI Biomedicine Service Mergers & Acquisitions Activity
Table 18. United States VS China AI Biomedicine Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Biomedicine Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Biomedicine Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Biomedicine Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Biomedicine Service Revenue Market Share (2021-2026)
Table 23. China Based AI Biomedicine Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Biomedicine Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Biomedicine Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Biomedicine Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Biomedicine Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Biomedicine Service Revenue Market Share (2021-2026)
Table 29. World AI Biomedicine Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Biomedicine Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Biomedicine Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Biomedicine Service Market Size by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Biomedicine Service Market Size Value by Data Type & Modality (2021-2026) & (USD Million)
Table 34. World AI Biomedicine Service Market Size by Data Type & Modality (2027-2032) & (USD Million)
Table 35. World AI Biomedicine Service Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Biomedicine Service Market Size Value by Service Delivery Model (2021-2026) & (USD Million)
Table 37. World AI Biomedicine Service Market Size by Service Delivery Model (2027-2032) & (USD Million)
Table 38. World AI Biomedicine Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Biomedicine Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Biomedicine Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Abcellera Biologics Basic Information, Manufacturing Base and Competitors
Table 42. Abcellera Biologics Major Business
Table 43. Abcellera Biologics AI Biomedicine Service Product and Services
Table 44. Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Abcellera Biologics Recent Developments/Updates
Table 46. Abcellera Biologics Competitive Strengths & Weaknesses
Table 47. Evotec Basic Information, Manufacturing Base and Competitors
Table 48. Evotec Major Business
Table 49. Evotec AI Biomedicine Service Product and Services
Table 50. Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Evotec Recent Developments/Updates
Table 52. Evotec Competitive Strengths & Weaknesses
Table 53. Atomwise Basic Information, Manufacturing Base and Competitors
Table 54. Atomwise Major Business
Table 55. Atomwise AI Biomedicine Service Product and Services
Table 56. Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Atomwise Recent Developments/Updates
Table 58. Atomwise Competitive Strengths & Weaknesses
Table 59. XtalPi Basic Information, Manufacturing Base and Competitors
Table 60. XtalPi Major Business
Table 61. XtalPi AI Biomedicine Service Product and Services
Table 62. XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. XtalPi Recent Developments/Updates
Table 64. XtalPi Competitive Strengths & Weaknesses
Table 65. PathAI Basic Information, Manufacturing Base and Competitors
Table 66. PathAI Major Business
Table 67. PathAI AI Biomedicine Service Product and Services
Table 68. PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. PathAI Recent Developments/Updates
Table 70. PathAI Competitive Strengths & Weaknesses
Table 71. Paige AI Basic Information, Manufacturing Base and Competitors
Table 72. Paige AI Major Business
Table 73. Paige AI AI Biomedicine Service Product and Services
Table 74. Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Paige AI Recent Developments/Updates
Table 76. Paige AI Competitive Strengths & Weaknesses
Table 77. HotSpot Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. HotSpot Therapeutics Major Business
Table 79. HotSpot Therapeutics AI Biomedicine Service Product and Services
Table 80. HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. HotSpot Therapeutics Recent Developments/Updates
Table 82. HotSpot Therapeutics Competitive Strengths & Weaknesses
Table 83. Scorpion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Scorpion Therapeutics Major Business
Table 85. Scorpion Therapeutics AI Biomedicine Service Product and Services
Table 86. Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Scorpion Therapeutics Recent Developments/Updates
Table 88. Scorpion Therapeutics Competitive Strengths & Weaknesses
Table 89. Charm Therapeutics Basic Information, Manufacturing Base and Competitors
Table 90. Charm Therapeutics Major Business
Table 91. Charm Therapeutics AI Biomedicine Service Product and Services
Table 92. Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Charm Therapeutics Recent Developments/Updates
Table 94. Charm Therapeutics Competitive Strengths & Weaknesses
Table 95. LifeMine Therapeutics Basic Information, Manufacturing Base and Competitors
Table 96. LifeMine Therapeutics Major Business
Table 97. LifeMine Therapeutics AI Biomedicine Service Product and Services
Table 98. LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. LifeMine Therapeutics Recent Developments/Updates
Table 100. LifeMine Therapeutics Competitive Strengths & Weaknesses
Table 101. C4XD Discovery Basic Information, Manufacturing Base and Competitors
Table 102. C4XD Discovery Major Business
Table 103. C4XD Discovery AI Biomedicine Service Product and Services
Table 104. C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. C4XD Discovery Recent Developments/Updates
Table 106. C4XD Discovery Competitive Strengths & Weaknesses
Table 107. Wave Life Sciences Basic Information, Manufacturing Base and Competitors
Table 108. Wave Life Sciences Major Business
Table 109. Wave Life Sciences AI Biomedicine Service Product and Services
Table 110. Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Wave Life Sciences Recent Developments/Updates
Table 112. Wave Life Sciences Competitive Strengths & Weaknesses
Table 113. Westlake Omics Basic Information, Manufacturing Base and Competitors
Table 114. Westlake Omics Major Business
Table 115. Westlake Omics AI Biomedicine Service Product and Services
Table 116. Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Westlake Omics Recent Developments/Updates
Table 118. Westlake Omics Competitive Strengths & Weaknesses
Table 119. IIpharma Basic Information, Manufacturing Base and Competitors
Table 120. IIpharma Major Business
Table 121. IIpharma AI Biomedicine Service Product and Services
Table 122. IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. IIpharma Recent Developments/Updates
Table 124. IIpharma Competitive Strengths & Weaknesses
Table 125. Global Key Players of AI Biomedicine Service Upstream (Raw Materials)
Table 126. Global AI Biomedicine Service Typical Customers
Table 1. World AI Biomedicine Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Biomedicine Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Biomedicine Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Biomedicine Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Biomedicine Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Biomedicine Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Biomedicine Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Biomedicine Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Biomedicine Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Biomedicine Service Players in 2025
Table 12. World AI Biomedicine Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Biomedicine Service Company Evaluation Quadrant
Table 14. Head Office of Key AI Biomedicine Service Players
Table 15. AI Biomedicine Service Market: Company Product Type Footprint
Table 16. AI Biomedicine Service Market: Company Product Application Footprint
Table 17. AI Biomedicine Service Mergers & Acquisitions Activity
Table 18. United States VS China AI Biomedicine Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Biomedicine Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Biomedicine Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Biomedicine Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Biomedicine Service Revenue Market Share (2021-2026)
Table 23. China Based AI Biomedicine Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Biomedicine Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Biomedicine Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Biomedicine Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Biomedicine Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Biomedicine Service Revenue Market Share (2021-2026)
Table 29. World AI Biomedicine Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Biomedicine Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Biomedicine Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Biomedicine Service Market Size by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Biomedicine Service Market Size Value by Data Type & Modality (2021-2026) & (USD Million)
Table 34. World AI Biomedicine Service Market Size by Data Type & Modality (2027-2032) & (USD Million)
Table 35. World AI Biomedicine Service Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Biomedicine Service Market Size Value by Service Delivery Model (2021-2026) & (USD Million)
Table 37. World AI Biomedicine Service Market Size by Service Delivery Model (2027-2032) & (USD Million)
Table 38. World AI Biomedicine Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World AI Biomedicine Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World AI Biomedicine Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Abcellera Biologics Basic Information, Manufacturing Base and Competitors
Table 42. Abcellera Biologics Major Business
Table 43. Abcellera Biologics AI Biomedicine Service Product and Services
Table 44. Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Abcellera Biologics Recent Developments/Updates
Table 46. Abcellera Biologics Competitive Strengths & Weaknesses
Table 47. Evotec Basic Information, Manufacturing Base and Competitors
Table 48. Evotec Major Business
Table 49. Evotec AI Biomedicine Service Product and Services
Table 50. Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Evotec Recent Developments/Updates
Table 52. Evotec Competitive Strengths & Weaknesses
Table 53. Atomwise Basic Information, Manufacturing Base and Competitors
Table 54. Atomwise Major Business
Table 55. Atomwise AI Biomedicine Service Product and Services
Table 56. Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Atomwise Recent Developments/Updates
Table 58. Atomwise Competitive Strengths & Weaknesses
Table 59. XtalPi Basic Information, Manufacturing Base and Competitors
Table 60. XtalPi Major Business
Table 61. XtalPi AI Biomedicine Service Product and Services
Table 62. XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. XtalPi Recent Developments/Updates
Table 64. XtalPi Competitive Strengths & Weaknesses
Table 65. PathAI Basic Information, Manufacturing Base and Competitors
Table 66. PathAI Major Business
Table 67. PathAI AI Biomedicine Service Product and Services
Table 68. PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. PathAI Recent Developments/Updates
Table 70. PathAI Competitive Strengths & Weaknesses
Table 71. Paige AI Basic Information, Manufacturing Base and Competitors
Table 72. Paige AI Major Business
Table 73. Paige AI AI Biomedicine Service Product and Services
Table 74. Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Paige AI Recent Developments/Updates
Table 76. Paige AI Competitive Strengths & Weaknesses
Table 77. HotSpot Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. HotSpot Therapeutics Major Business
Table 79. HotSpot Therapeutics AI Biomedicine Service Product and Services
Table 80. HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. HotSpot Therapeutics Recent Developments/Updates
Table 82. HotSpot Therapeutics Competitive Strengths & Weaknesses
Table 83. Scorpion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. Scorpion Therapeutics Major Business
Table 85. Scorpion Therapeutics AI Biomedicine Service Product and Services
Table 86. Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Scorpion Therapeutics Recent Developments/Updates
Table 88. Scorpion Therapeutics Competitive Strengths & Weaknesses
Table 89. Charm Therapeutics Basic Information, Manufacturing Base and Competitors
Table 90. Charm Therapeutics Major Business
Table 91. Charm Therapeutics AI Biomedicine Service Product and Services
Table 92. Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Charm Therapeutics Recent Developments/Updates
Table 94. Charm Therapeutics Competitive Strengths & Weaknesses
Table 95. LifeMine Therapeutics Basic Information, Manufacturing Base and Competitors
Table 96. LifeMine Therapeutics Major Business
Table 97. LifeMine Therapeutics AI Biomedicine Service Product and Services
Table 98. LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. LifeMine Therapeutics Recent Developments/Updates
Table 100. LifeMine Therapeutics Competitive Strengths & Weaknesses
Table 101. C4XD Discovery Basic Information, Manufacturing Base and Competitors
Table 102. C4XD Discovery Major Business
Table 103. C4XD Discovery AI Biomedicine Service Product and Services
Table 104. C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. C4XD Discovery Recent Developments/Updates
Table 106. C4XD Discovery Competitive Strengths & Weaknesses
Table 107. Wave Life Sciences Basic Information, Manufacturing Base and Competitors
Table 108. Wave Life Sciences Major Business
Table 109. Wave Life Sciences AI Biomedicine Service Product and Services
Table 110. Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Wave Life Sciences Recent Developments/Updates
Table 112. Wave Life Sciences Competitive Strengths & Weaknesses
Table 113. Westlake Omics Basic Information, Manufacturing Base and Competitors
Table 114. Westlake Omics Major Business
Table 115. Westlake Omics AI Biomedicine Service Product and Services
Table 116. Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Westlake Omics Recent Developments/Updates
Table 118. Westlake Omics Competitive Strengths & Weaknesses
Table 119. IIpharma Basic Information, Manufacturing Base and Competitors
Table 120. IIpharma Major Business
Table 121. IIpharma AI Biomedicine Service Product and Services
Table 122. IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. IIpharma Recent Developments/Updates
Table 124. IIpharma Competitive Strengths & Weaknesses
Table 125. Global Key Players of AI Biomedicine Service Upstream (Raw Materials)
Table 126. Global AI Biomedicine Service Typical Customers
LIST OF FIGURES
Figure 1. AI Biomedicine Service Picture
Figure 2. World AI Biomedicine Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Biomedicine Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Biomedicine Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Biomedicine Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 13. AI Biomedicine Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Biomedicine Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Biomedicine Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Biomedicine Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Biomedicine Service Markets in 2025
Figure 27. United States VS China: AI Biomedicine Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Biomedicine Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Biomedicine Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Biomedicine Service Market Size Market Share by Type in 2025
Figure 31. AI-driven Drug Discovery Services
Figure 32. AI-based Preclinical Research Services
Figure 33. AI-enabled Clinical Trial Services
Figure 34. AI Biomarker & Companion Diagnostic Services
Figure 35. Others
Figure 36. World AI Biomedicine Service Market Size Market Share by Type (2021-2032)
Figure 37. World AI Biomedicine Service Market Size by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Figure 38. World AI Biomedicine Service Market Size Market Share by Data Type & Modality in 2025
Figure 39. Genomics & Multi-omics AI Services
Figure 40. Medical Imaging & Digital Pathology AI Services
Figure 41. Chemical & Molecular Structure AI Services
Figure 42. Clinical & EHR Data AI Services
Figure 43. Others
Figure 44. World AI Biomedicine Service Market Size Market Share by Data Type & Modality (2021-2032)
Figure 45. World AI Biomedicine Service Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Figure 46. World AI Biomedicine Service Market Size Market Share by Service Delivery Model in 2025
Figure 47. Project-based AI Research Services
Figure 48. Subscription-based AI Platforms (Service Mode)
Figure 49. AI-as-a-Service (API / Cloud-based)
Figure 50. Others
Figure 51. World AI Biomedicine Service Market Size Market Share by Service Delivery Model (2021-2032)
Figure 52. World AI Biomedicine Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World AI Biomedicine Service Market Size Market Share by Application in 2025
Figure 54. Pharmaceutical & Biotech Companies
Figure 55. CRO / CDMO-oriented Companies
Figure 56. Academic & Research Institutes
Figure 57. Others
Figure 58. World AI Biomedicine Service Market Size Market Share by Application (2021-2032)
Figure 59. AI Biomedicine Service Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
Figure 1. AI Biomedicine Service Picture
Figure 2. World AI Biomedicine Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Biomedicine Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Biomedicine Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Biomedicine Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Biomedicine Service Revenue (2021-2032) & (USD Million)
Figure 13. AI Biomedicine Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Biomedicine Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Biomedicine Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Biomedicine Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Biomedicine Service Markets in 2025
Figure 27. United States VS China: AI Biomedicine Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Biomedicine Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Biomedicine Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Biomedicine Service Market Size Market Share by Type in 2025
Figure 31. AI-driven Drug Discovery Services
Figure 32. AI-based Preclinical Research Services
Figure 33. AI-enabled Clinical Trial Services
Figure 34. AI Biomarker & Companion Diagnostic Services
Figure 35. Others
Figure 36. World AI Biomedicine Service Market Size Market Share by Type (2021-2032)
Figure 37. World AI Biomedicine Service Market Size by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Figure 38. World AI Biomedicine Service Market Size Market Share by Data Type & Modality in 2025
Figure 39. Genomics & Multi-omics AI Services
Figure 40. Medical Imaging & Digital Pathology AI Services
Figure 41. Chemical & Molecular Structure AI Services
Figure 42. Clinical & EHR Data AI Services
Figure 43. Others
Figure 44. World AI Biomedicine Service Market Size Market Share by Data Type & Modality (2021-2032)
Figure 45. World AI Biomedicine Service Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Figure 46. World AI Biomedicine Service Market Size Market Share by Service Delivery Model in 2025
Figure 47. Project-based AI Research Services
Figure 48. Subscription-based AI Platforms (Service Mode)
Figure 49. AI-as-a-Service (API / Cloud-based)
Figure 50. Others
Figure 51. World AI Biomedicine Service Market Size Market Share by Service Delivery Model (2021-2032)
Figure 52. World AI Biomedicine Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World AI Biomedicine Service Market Size Market Share by Application in 2025
Figure 54. Pharmaceutical & Biotech Companies
Figure 55. CRO / CDMO-oriented Companies
Figure 56. Academic & Research Institutes
Figure 57. Others
Figure 58. World AI Biomedicine Service Market Size Market Share by Application (2021-2032)
Figure 59. AI Biomedicine Service Industrial Chain
Figure 60. Methodology
Figure 61. Research Process and Data Source
